Feedback (LON:FDBK) Stock Price Crosses Above 50 Day Moving Average – Time to Sell?

Feedback plc (LON:FDBK)’s share price passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 12.30 and traded as high as GBX 13.50. Feedback shares last traded at GBX 12.70, with a volume of 50,875 shares trading hands.

Feedback Stock Performance

The stock has a market cap of £5.56 million, a PE ratio of -0.81 and a beta of 0.77. The company’s 50-day moving average price is GBX 12.30 and its 200 day moving average price is GBX 10.67.

Feedback (LON:FDBK) last posted its earnings results on Tuesday, February 17th. The company reported GBX (3.98) earnings per share (EPS) for the quarter. Feedback had a negative return on equity of 135.17% and a negative net margin of 845.25%. As a group, equities research analysts predict that Feedback plc will post -8 earnings per share for the current fiscal year.

Insider Activity at Feedback

In other news, insider Emma Oswick (Stuart) purchased 60,459 shares of the firm’s stock in a transaction on Tuesday, December 23rd. The shares were bought at an average cost of GBX 8 per share, for a total transaction of £4,836.72. Also, insider Tom Oakley purchased 60,904 shares of the stock in a transaction dated Tuesday, December 23rd. The shares were purchased at an average price of GBX 8 per share, with a total value of £4,872.32. 7.98% of the stock is currently owned by company insiders.

Feedback Company Profile

Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical.

Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.

By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.

Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.